Key result
18F-labeled ECL1i-based CCR2-targeted PET radiotracer shows promise for imaging cardiac inflammation.
Hypothesis-generating for CCR2-targeted cardiac inflammation imaging; clinical translation studies needed before any adoption.
-ECL1i as a promising CCR2-targeted PET radiotracer for imaging cardiac inflammation.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question. An 18F-labeled ECL1i-based CCR2-targeted PET radiotracer demonstrates promise for imaging cardiac inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: